A5057266340- Coronary Interventions and Diagnostics
- Acute Myocardial Infarction Research
- Cardiac Imaging and Diagnostics
- Peripheral Artery Disease Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Cerebrovascular and Carotid Artery Diseases
- Pain Management and Treatment
- Cardiovascular Issues in Pregnancy
- Medical Imaging and Pathology Studies
- Atrial Fibrillation Management and Outcomes
- Thyroid and Parathyroid Surgery
- Thermal Regulation in Medicine
- Intracranial Aneurysms: Treatment and Complications
- Long-Term Effects of COVID-19
- Retinal and Macular Surgery
- Cardiac, Anesthesia and Surgical Outcomes
- Neurological Disorders and Treatments
- Heart Failure Treatment and Management
- COVID-19 Clinical Research Studies
- Radiopharmaceutical Chemistry and Applications
- Cardiovascular Health and Disease Prevention
- Connective tissue disorders research
- Cardiac Valve Diseases and Treatments
- Cardiac electrophysiology and arrhythmias
- Aortic Disease and Treatment Approaches
Medical University of Silesia
2021-2022
Witelon State University of Applied Sciences in Legnica
2022
Background: Whereas the efficacy and safety of intravascular lithotripsy (IVL) have been confirmed in de novo calcified coronary lesions, little is known about its utility treating stent underexpansion. This study aimed to investigate impact IVL Methods Results: Consecutive patients with underexpansion treated entered multicenter IVL-Dragon Registry. The procedural success (primary endpoint) was defined as a relative expansion >80%. Thirty days device-oriented composite endpoint (DOCE)...
The unprotected calcified Left Main disease represents a high-risk subset for percutaneous coronary intervention (PCI), and it is associated with higher number of periprocedural complications an increased rate in-stent thrombosis restenosis. Adequate lesion preparation plays crucial role in achieving favorable PCI outcome. Rotational Atherectomy (RA) well-established plaque-modifying method; nevertheless, the data regarding effectiveness RA LM diseases scarce. Recently, novel...
WHAT'S NEW?Stent underexpansion is associated with increased risk of in stent restenosis or thrombosis.Dedicated technologies intravascular coronary lithotripsy (IVL) excimer laser atherectomy (ELCA) are an effective tool for PCI de novo calcified lesions.The data from IVL-ELCA DRAGON Registry showed a good immediate angiographic and imaging outcome the treatment 4 lesions by IVL ELCA.PCI underexpanded stents ELCA devices safe comparable device success rate.
Refractory angina (RA) due to the lack of therapeutic options still remains a significant challenge. Coronary Sinus Reducer (CSR) has been recently introduced in field therapy this advance form Artery disease (CAD). However, despite growing evidence data from routine clinical practice are scar. 12-month observation efficacy and safety (ShockWave Medical, Santa Clara, USA), based on results Lower Silesia Registry (NCT06288165). The study includes 67 consecutive patients diagnosed with chronic...
Background/Objectives: Current evidence suggests that levosimendan may have a beneficial effect in the treatment of acute heart failure (AHF) or cardiogenic shock following primary percutaneous coronary intervention (PCI). However, there is paucity data on use prior to PCI. Therefore, our pilot study aimed assess short-term prognosis new therapeutic protocol involving preprocedural infusion patients with reduced left ventricular ejection fraction undergoing high-risk PCI for syndrome (ACS)....
Background: Coronary calcifications, particularly in left main disease (LMD), are independently associated with adverse outcomes of percutaneous coronary intervention (PCI). Adequate lesion preparation is pivotal to achieve favorable short- and long-term outcomes. Rotational atherectomy devices have been used contemporary practice obtain adequate the calcified lesions. Recently, novel orbital (OA) introduced clinical facilitate lesion. The objective this study compare short-term safety...
Percutaneous coronary intervention (PCI) in the acute syndrome (ACS) setting is associated with a greater probability of device failure. The currently ongoing development new scaffold technologies has concentrated an effort on improving PCI outcomes, including use biodegradable materials. This pilot study evaluates performance magnesium bioresorbable (Magmaris, Biotronik, Germany) comparison to sirolimus-eluting polymer stents (BP-SES) (Ultimaster, Terumo, Japan) NSTE-ACS setting.The...
Background: Acute coronary syndrome (ACS) as a clinical manifestation of artery disease (CAD) remains significant cause mortality and morbidity, reported worldwide annually. The second generation drug-eluting stents (DES) is gold standard in percutaneous interventions ACS patients however, permanent caging the vessel with metallic DES has some drawbacks. Bioresorbable vascular scaffolds (BRS) were designed temporal vessel-supporting technology allowing for anatomical functional restoration....
Heavy calcification remains one of the greatest challenges in treatment coronary artery disease (CAD), especially subjects with an acute syndrome (ACS). In present case series study high-risk patients ACS, including both STEMI and NSTEMI, we performed a rota-lithotripsy—a combination rotational atherectomy subsequent intravascular lithotripsy—as novel bail-out strategy to facilitate stent delivery tortuous calcified artery.
Left main (LM) disease is associated with a large myocardial ischemic territory. Calcification co-existing undilatable lesions predictor of poor clinical outcomes following LM percutaneous coronary interventions (PCI).
Data regarding the clinical outcomes of covered stents (CSs) used to seal coronary artery perforations (CAPs) in all-comer population are scarce. The aim CRACK Registry was evaluate procedural, 30-days and 1-year after CAP treated by CS implantation.
In conclusion, the prevalence of CMD in long-COVID--19 subjects is similar to that observed patients with symptomatic non-obstructive CAD [11,12].Future studies are necessary fully understand etiopathogenesis long COVID-19.
Background: Research on the resorbable magnesium scaffolds (RMSs) has shown their safety and effectiveness in stable clinical conditions. It seems that this new therapeutic option could be promising for selected acute coronary syndrome (ACS) patients. Aims: Our analysis aims to analyse long-term performance of RMSs among ACS Methods: The study population consisted consecutive patients treated with implantation at least one RMS. Magmaris Registry was designed as a single-arm observational...
Background: Despite continuous improvements in revascularization techniques, refractory angina without potential options remains a relevant clinical issue with significant impact on patient’s quality of life. Recently, novel device, the Coronary Sinus Reducer (CSR), has been introduced into practice as therapeutic option for patients disabling pectoris. In this single-center, observational study, we evaluated mid-term (3-month) safety and efficacy CSR real-world cohort. Methods: The study...
Background: Diabetes mellitus (DM) is one of the major risk factors contributing to Acute Coronary Syndromes (ACS) and associated with an increased adverse clinical outcomes following percutaneous coronary intervention (PCI), even when second generation drug-eluting stents (DES) used. In order overcome disadvantages permanent caging a vessel metallic DES, bioresorbable scaffold (BRS) technology has been recently developed. However, prognosis patients DM ACS treated PCI via subsequent...
Background: The successful percutaneous coronary intervention (PCI) in chronic total occlusion (CTO) improves the long-term outcome patients with artery disease (CAD). Heavy calcification remains one of strongest predictors an unfavorable PCI. In this case series study, shockwave intravascular lithotripsy (S-IVL)-a novel balloon-based system facilitating modification calcified lesions was evaluated. Methods: study population consisted five heavily calcified, undilatable-CTOs treated S-IVL...
Background: Despite continuous improvements in revascularization techniques, refractory angina without potential options remains a relevant clinical issue with significant impact on the patient’s quality of life. Recently, novel device, Coronary Sinus Reducer (CSR), has been introduced into practice as therapeutic option for patients disabling pectoris. In this single-center, observational study, we evaluated mid-term (3-month) safety and efficacy CSR real-world cohort. Methods: The study...
Data on the clinical outcomes comparing synthetic fluorocarbon polymer polytetrafluoroethylene- (PTFE, GraftMaster) and polyurethane- (Papyrus) covered stents (CSs) to seal coronary artery perforations (CAPs) are limited. We aimed evaluate 30-day 1-year after PCI complicated by CAP treated with CS. assessed 106 consecutive patients successful sealing (122 CSs): GraftMaster (51 patients, 57 CSs) or Papyrus CS (55 65 CSs). The primary endpoint was occurrence of major adverse cardiac events...
Background. Cardiovascular disease (CVD) with significant involvement of coronary artery (CAD) remains a major cause death and disability among the diabetic population. Although percutaneous intervention (PCI) continues to evolve, type 2 diabetes mellitus (T2DM) is well-established marker poor clinical prognosis after PCI, which mainly attributed rapid progression atherosclerosis requiring recurrent revascularizations. Hence, use bioresorbable materials could provide some solution this...